Difference between revisions of "Team:Shenzhen SFLS/HP/Interview in Peking University Shenzhen Hospital"
| Line 61: | Line 61: | ||
<div class="mainpage mainpage1"> | <div class="mainpage mainpage1"> | ||
<!-- <h5 id="index_1">Former Project — Treatment of Trichophyton rubrum infection by β-human defensin-3.</h5> --> | <!-- <h5 id="index_1">Former Project — Treatment of Trichophyton rubrum infection by β-human defensin-3.</h5> --> | ||
| − | <p>On June 17, 2017, we had an interview with Dr. Boran Cheng, an expert in the Department of Oncology, Peking University Shenzhen Hospital. From the communication, we learnt: 1) Current primary treatment of cancer is surgery; 2) Early diagnosis significantly improve the survival rate of patients; 3) Gene therapy and immunotherapy may cure cancer in the future. About CRISPR/CAS9 system in the treatment of cancer, Dr. Cheng believed | + | <p>On June 17, 2017, we had an interview with Dr. Boran Cheng, an expert in the Department of Oncology, Peking University Shenzhen Hospital. From the communication, we learnt: 1) Current primary treatment of cancer is surgery; 2) Early diagnosis significantly improve the survival rate of patients; 3) Gene therapy and immunotherapy may cure cancer in the future. About CRISPR/CAS9 system in the treatment of cancer, Dr. Cheng believed that it is a promising therapy, but there will be a long way to go for its development. </p> |
<div class="picture"> | <div class="picture"> | ||
<img src="https://static.igem.org/mediawiki/2017/4/44/Sfls-hp-PKU-interview.jpeg" width="500"> | <img src="https://static.igem.org/mediawiki/2017/4/44/Sfls-hp-PKU-interview.jpeg" width="500"> | ||
Latest revision as of 13:56, 1 November 2017
On June 17, 2017, we had an interview with Dr. Boran Cheng, an expert in the Department of Oncology, Peking University Shenzhen Hospital. From the communication, we learnt: 1) Current primary treatment of cancer is surgery; 2) Early diagnosis significantly improve the survival rate of patients; 3) Gene therapy and immunotherapy may cure cancer in the future. About CRISPR/CAS9 system in the treatment of cancer, Dr. Cheng believed that it is a promising therapy, but there will be a long way to go for its development.
